A Phase 2a, Multicenter, Randomized, Double-masked, Placebo-controlled, Parallel-group Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2015
Price : $35 *
At a glance
- Drugs PHP 201 (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Amakem
- 20 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jun 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 16 May 2014 New trial record